Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Zwiener who wrote (209)	7/9/1997 9:03:00 PM
From: James Silverman	of 10280

John-I wouldnt go so far as to say that the FDA will pull approvals for a racemic drug with side effects. Two single isomer versions of existing drugs have been approved in the past year, one is IPIC obesity drug the other is a J&J antibiotic. Neither of the racemic versions have been pulled. If you are implying that albuterol will be pulled with levalbuterol approval, you are making a very aggressive assumption. If that happened SEPR would sell for about $500 in a couple of years and I would retire at the ripe age of 31 :-)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next